Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

BACKGROUND: Hematopoieticic stem cell transplantation is the only therapeutic option that can cure thalassemia disease. Reduced intensity hematopoietic stem cell transplantation (RI-HSCT) has demonstrated a high cure rate with minimal complications compared to other options. Because RI-HSCT is very...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sruamsiri, Rosarin, Chaiyakunapruk, Nathorn, Pakakasama, Samart, Sirireung, Somtawin, Sripaiboonkij, Nintita, Bunworasate, Udomsak, Hongeng, Suradej
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583808/
https://ncbi.nlm.nih.gov/pubmed/23379888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-13-45
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados